Levothyroxine Sodium
NDC 0615-8650, Levothyroxine Sodium, tablet, from NCS HealthCare of KY, LLC dba Vangard Labs.
- Product NDC
- 0615-8650
- Status
- Listed
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021210
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0615-8650 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOTHYROXINE SODIUM.15 mg/1
Pharmacologic classes
Thyroxine [CS]; l-Thyroxine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0615-8650-14 | 00615865014 | 14 TABLET in 1 BLISTER PACK (0615-8650-14) |
| 0615-8650-39 | 00615865039 | 30 TABLET in 1 BLISTER PACK (0615-8650-39) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/abe173cc-1579-43a5-b12d-a31958d0a539
Use it
Look up 0615-8650 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0615-8650 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0615-8650. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.